This cohort study evaluates the association of kidney function with risk of diagnosis of incident Alzheimer disease or dementia and with the blood biomarkers neurofilament light, phosphorylated tau, and glial fibrillary acidic protein. The gene discussed is MAPT; the disease is dementia.